Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
285.4 SEK | +0.71% | +6.10% | +6.89% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+6.89% | 8.81B | |
-3.45% | 87.17B | |
+1.97% | 40.1B | |
+57.79% | 25.12B | |
-14.82% | 15.59B | |
-8.82% | 12B | |
-16.29% | 11.8B | |
-41.58% | 11.8B | |
-10.53% | 8.24B | |
+0.95% | 7.62B |
- Stock Market
- Equities
- SOBI Stock
- News Swedish Orphan Biovitrum AB
- Sobi, Apellis Dose First Patient In Phase 3 Study Of Pegcetacoplan For Rare Kidney Diseases